CFDE Data Portal | Search LOC101928557

	Label	Description
	LOC101928557 Gene (Entity type)	ENSG00000270159 - uncharacterized LOC101928557
	GSE195663 cisplatin 7 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE195559 NOTCH1 knockout endothelial cell cardiac muscle cell stem cell 0 v 9 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE205714 GSE229013 adenosine 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE77108 saha 6 v 9 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE202744 CDK9 inhibition Toyocamycin 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE218773 ABL2 knockdown Hep-G2 3 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE202744 CDK9 inhibition Toyocamycin 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE193964 MI-1 Kasumi-1 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS

LOC101928557

ENSG00000270159 - uncharacterized LOC101928557

GSE195663 cisplatin 7 v 1 human up

A Gene Set from LINCS

GSE195559 NOTCH1 knockout endothelial cell cardiac muscle cell stem cell 0 v 9 human up

A Gene Set from LINCS

GSE205714 GSE229013 adenosine 3 v 2 human up

A Gene Set from LINCS

GSE77108 saha 6 v 9 human up

A Gene Set from LINCS

GSE202744 CDK9 inhibition Toyocamycin 1 v 3 human up

A Gene Set from LINCS

GSE218773 ABL2 knockdown Hep-G2 3 v 1 human up

A Gene Set from LINCS

GSE202744 CDK9 inhibition Toyocamycin 1 v 0 human dn

A Gene Set from LINCS

GSE193964 MI-1 Kasumi-1 1 v 0 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.